No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
CASI Pharmaceuticals (CASI) Up on Buyout Offer for China Business
CASI Pharmaceuticals Shares Are Trading Higher After the Company Announced Plans to Submit an Investigational New Drug Application to the FDA for CID-103 for the Treatment of Antibody-mediated Rejection in Kidney Transplant Recipients. Also, the...
Market-Moving News for June 27th
US Futures Trend Lower Pre-Bell as Investors Await Slew of Economic Data
Top Premarket Gainers
CASI Pharmaceuticals Sees Dramatic After-Hours Surge